NEW YORK – A newly published multisite clinical trial has shown that the Roche Cobas Liat SARS-CoV-2 assay has accuracy comparable to laboratory-based RT-PCR tests. The 20-minute point-of-care test had nearly 99 percent agreement with testing in the lab on the Roche 6800 and 8800 instruments.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.